Royalty Pharma plc (RPRX)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:218
% of all portfolios:0.065%
Hold Price * :$28.09
History Portfolio Manager Activity Share change % change to portfolio
Q4  2023
Torray Funds Add 22.56% 93,107 0.42
Viking Global Investors Add 6.58% 623,216 0.06
Samantha McLemore - Patient Capital Management Buy 1,254,780 1.87
Q3  2023
Torray Funds Reduce 0.29% 1,182 0.01
Viking Global Investors Reduce 3.93% 386,731 0.04
Q2  2023
Torray Funds Add 201.68% 276,643 1.47
Viking Global Investors Reduce 12.08% 1,353,317 0.17
Q1  2023
Viking Global Investors Add 11.95% 1,195,738 0.20
Torray Funds Reduce 0.14% 199 0.00
Q4  2022
Torray Funds Reduce 1.19% 1,653 0.01
Viking Global Investors Reduce 8.02% 873,083 0.17
Q3  2022
Torray Funds Add 0.01% 12 0.00
Viking Global Investors Reduce 12.04% 1,489,100 0.28
Q2  2022
Viking Global Investors Add 14.92% 1,606,222 0.31
Torray Funds Add 5.26% 6,942 0.06
Warren Buffett - Berkshire Hathaway Sell 100.00% 1,496,372 0.02
Q1  2022
Viking Global Investors Add 4.35% 449,094 0.07
Torray Funds Reduce 4.26% 5,871 0.04
Warren Buffett - Berkshire Hathaway Reduce 82.70% 7,151,896 0.10
Q4  2021
Viking Global Investors Add 149.13% 6,174,870 0.71
Torray Funds Buy 137,941 0.81
Warren Buffett - Berkshire Hathaway Reduce 34.21% 4,497,634 0.05
Q3  2021
Viking Global Investors Add 27.85% 901,854 0.09
Warren Buffett - Berkshire Hathaway Buy 13,145,902 0.16
Q2  2021
Viking Global Investors Add 57.08% 1,176,901 0.15
Lee Ainslie - Maverick Capital Sell 100.00% 7,342 0.00
Q1  2021
Lee Ainslie - Maverick Capital Buy 7,342 0.00
Viking Global Investors Reduce 9.85% 225,247 0.03
Q4  2020
Viking Global Investors Add 17.40% 338,936 0.05
Q3  2020
Viking Global Investors Reduce 22.54% 566,921 0.09
Q2  2020
Viking Global Investors Buy 2,514,985 0.53

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.